Atopic Dermatitis

Results from a phase 1 study show that KT-474 reduced disease-relevant inflammatory biomarkers in the blood and skin of patients with hidradenitis suppurativa or atopic dermatitis, according to a Kymera Therapeutics press release.

Tezspire reduced asthma exacerbations across all seasons, regardless of sensitivities to perennial and seasonal aeroallergens, a recent study showed.

ANAHEIM, Calif. — Tapinarof cream was well tolerated and significantly improved itch in adults and children aged as young as 2 years with atopic dermatitis, according to a poster presentation here.

In patients with atopic dermatitis treated with dupilumab, a reversible and most likely benign lymphoid reaction could occur, according to a study.

ANAHEIM, Calif. — Patients with atopic dermatitis achieved long-term disease control with as-needed use of ruxolitinib cream, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

ANAHEIM, Calif. — Patients with atopic dermatitis have an increased likelihood of developing anxiety and depression, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Patients with atopic dermatitis with comorbidities face additional treatment burdens and barriers, according to a study published in Annals of Allergy, Asthma & Immunology.

Patients being treated for atopic dermatitis with dupilumab had good reproducibility with patch testing for allergic contact dermatitis, according to a study.

Maintenance dosing of lebrikizumab sustained skin clearance, relieved itch and reduced disease severity for up to 2 years in patients with moderate to severe atopic dermatitis, Eli Lilly and Company announced in a press release.